Cargando…
Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women
Lead readily crosses the placenta and displays adverse effects on birth outcomes and neurodevelopment. Systematic identification of the risk of exposure during pregnancy is essential but rarely performed, probably due to hospital staff’s workload and their lack of awareness. We aimed to evaluate the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763227/ https://www.ncbi.nlm.nih.gov/pubmed/33321747 http://dx.doi.org/10.3390/ijerph17249220 |
_version_ | 1783627968014188544 |
---|---|
author | Coiplet, Eléna Freuchet, Marine Sunyach, Claire Mancini, Julien Perrin, Jeanne Courbiere, Blandine Heckenroth, Hélène Pissier, Christel Hamdaoui, Naima Bretelle, Florence |
author_facet | Coiplet, Eléna Freuchet, Marine Sunyach, Claire Mancini, Julien Perrin, Jeanne Courbiere, Blandine Heckenroth, Hélène Pissier, Christel Hamdaoui, Naima Bretelle, Florence |
author_sort | Coiplet, Eléna |
collection | PubMed |
description | Lead readily crosses the placenta and displays adverse effects on birth outcomes and neurodevelopment. Systematic identification of the risk of exposure during pregnancy is essential but rarely performed, probably due to hospital staff’s workload and their lack of awareness. We aimed to evaluate the relevance of a questionnaire to screen pregnant women for lead exposure. A cross-sectional, multicentre study was carried out on a population of 792 pregnant women from February 2018 to May 2020. A total of 596 women had a blood lead test: 68.5% had blood lead levels below 10 μg/L. The estimated prevalence above 25 µg/L was 4% (95% confidence interval (CI) [2.6–5.9]) and 1.3% had levels above 50 µg/L (95% CI [0.6–2.6]). Multivariate analysis showed that three risk factors significantly increased the probability of blood lead levels above 25 µg/L: the use of traditional cosmetics (adjusted odds ratio [aOR]: 3.90; 95% CI [1.65–9.21]; p = 0.002), degraded old housing (aOR: 2.67; 95% CI [1.19–6.038]; p = 0.018), and (marginally) eating bread more than twice a day (aOR: 2.40; 95% CI [0.96–6.11]; p = 0.060). Our study reveals that a three-question tool can be used to quickly screen for the risk of lead exposure in our population and to trigger lead blood tests and special vigilance during pregnancy follow-up. |
format | Online Article Text |
id | pubmed-7763227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77632272020-12-27 Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women Coiplet, Eléna Freuchet, Marine Sunyach, Claire Mancini, Julien Perrin, Jeanne Courbiere, Blandine Heckenroth, Hélène Pissier, Christel Hamdaoui, Naima Bretelle, Florence Int J Environ Res Public Health Article Lead readily crosses the placenta and displays adverse effects on birth outcomes and neurodevelopment. Systematic identification of the risk of exposure during pregnancy is essential but rarely performed, probably due to hospital staff’s workload and their lack of awareness. We aimed to evaluate the relevance of a questionnaire to screen pregnant women for lead exposure. A cross-sectional, multicentre study was carried out on a population of 792 pregnant women from February 2018 to May 2020. A total of 596 women had a blood lead test: 68.5% had blood lead levels below 10 μg/L. The estimated prevalence above 25 µg/L was 4% (95% confidence interval (CI) [2.6–5.9]) and 1.3% had levels above 50 µg/L (95% CI [0.6–2.6]). Multivariate analysis showed that three risk factors significantly increased the probability of blood lead levels above 25 µg/L: the use of traditional cosmetics (adjusted odds ratio [aOR]: 3.90; 95% CI [1.65–9.21]; p = 0.002), degraded old housing (aOR: 2.67; 95% CI [1.19–6.038]; p = 0.018), and (marginally) eating bread more than twice a day (aOR: 2.40; 95% CI [0.96–6.11]; p = 0.060). Our study reveals that a three-question tool can be used to quickly screen for the risk of lead exposure in our population and to trigger lead blood tests and special vigilance during pregnancy follow-up. MDPI 2020-12-10 2020-12 /pmc/articles/PMC7763227/ /pubmed/33321747 http://dx.doi.org/10.3390/ijerph17249220 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Coiplet, Eléna Freuchet, Marine Sunyach, Claire Mancini, Julien Perrin, Jeanne Courbiere, Blandine Heckenroth, Hélène Pissier, Christel Hamdaoui, Naima Bretelle, Florence Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women |
title | Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women |
title_full | Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women |
title_fullStr | Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women |
title_full_unstemmed | Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women |
title_short | Assessment of a Screening Questionnaire to Identify Exposure to Lead in Pregnant Women |
title_sort | assessment of a screening questionnaire to identify exposure to lead in pregnant women |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763227/ https://www.ncbi.nlm.nih.gov/pubmed/33321747 http://dx.doi.org/10.3390/ijerph17249220 |
work_keys_str_mv | AT coipletelena assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT freuchetmarine assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT sunyachclaire assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT mancinijulien assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT perrinjeanne assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT courbiereblandine assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT heckenrothhelene assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT pissierchristel assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT hamdaouinaima assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen AT bretelleflorence assessmentofascreeningquestionnairetoidentifyexposuretoleadinpregnantwomen |